Tearlab Corp.
(Other OTC/NBB : TEAR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.03%84.800.8%$425.62m
MDTMedtronic PLC
1.00%102.770.6%$421.61m
TMOThermo Fisher Scientific Inc.
1.01%276.081.0%$389.59m
ALGNAlign Technology, Inc.
1.68%177.296.3%$345.04m
ISRGIntuitive Surgical, Inc.
-0.88%495.452.4%$306.57m
BDXBecton, Dickinson and Company
0.78%248.261.1%$264.67m
SYKStryker Corporation
0.79%216.991.3%$231.95m
EWEdwards Lifesciences Corporation
1.93%219.371.2%$226.79m
BSXBoston Scientific Corporation
0.67%42.151.1%$221.88m
BAXBaxter International Inc.
1.36%86.951.7%$206.72m
ZBHZimmer Biomet Holdings, Inc.
1.38%137.001.7%$202.42m
ABMDABIOMED, Inc.
0.50%193.013.3%$153.08m
DXCMDexCom, Inc.
3.25%163.688.3%$150.35m
WATWaters Corporation
1.62%205.543.8%$116.40m
IDXXIDEXX Laboratories, Inc.
0.86%275.413.7%$111.67m

Company Profile

TearLab Corp. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA.